This information was published on 2025-08-04T10:13:33 for IP Right Registration Published.
| Field | Value |
| (210) | 2519380 (IR 1836558) |
| (220) |
27 Dec 2024
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis. |
| (540) | REZDIFFRA |
| (550) | Word |
| (730) |
Madrigal Pharmaceuticals, Inc.
|
Find out more about publications on the About page.